HMGCR and neoplasm: HMGCR (3-hydroxy-3-methylglutaryl–coenzyme A reductase) is differentially expressed among breast cancers, with higher expression in the tumour cells (vs normal epithelial cells) (47), but the correlation with its expression and breast cancer prognosis and survival is controversial.